Skip to main content
Funded Studies

J. Willliam Langston, MD

Chief Scientific Officer and Founder at The Parkinson's Institute

Dr. J. William Langston is the Chief Scientific Officer and Founder of the Parkinson's Institute in Sunnyvale, California. A graduate of the University of Missouri School of Medicine, he served as a faculty member at Stanford University and Chairman of Neurology at Santa Clara Valley Medical Center in San Jose, California before founding the Parkinson's Institute. He is internationally recognized for the discovery of the link between a chemical known as MPTP and parkinsonism, which has provided a new tool to study Parkinson's disease and which also stimulated great interest in the possibility that environmental factors may play a role in causing the disease. His current research interests include the study of mechanisms of neuronal degeneration, defining the exact nature of PD and its etiology, and finding ways to accelerate drug discovery and development. To date, Dr. Langston has published 350 papers on PD and related disorders and has received many awards for his work, the most recent of which was the Robert J. Pritzker Prized for Leadership in Parkinson’s Research.  Dr. Langston serves on numerous editorial and advisory boards including the The Michael J. Fox Foundation. 


Associated Grants

  • Just in Time Pre-clinical Resource for Evaluating Symptoms & Side Effects and/or Dyskinesia Treatments

    2011


  • Pharmacokinetics and Cognitive Side Effects of the Antidyskinetic Drug Fenobam in MPTP-treated Pre-clinical Models

    2011


  • Assessing Heart Rate Variability (HRV) in the Parkinson's Associated Risk Study (PARS) Cohort

    2009


  • Validating the Electrocardiogram as a Tool to Identify Pre-motor Parkinson's Disease

    2009


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.